Differentiating the Clinical Presentations of Tardive Dyskinesia (TD) and Drug-Induced Parkinsonism Published 2024-02-16 Download video MP4 360p Recommendations 15:49 Standards of Care for Patients Taking Antipsychotic Drugs 17:05 Long-Term Management of Tardive Dyskinesia 08:52 Hear From an Expert: Long-term Results 09:36 Using the 4-Week Titration Kit 09:38 Hear From an Expert: SF-36 Results and Impact on Activities of Daily Living 02:18 The Mechanism of Action (MOA) 03:44 Moves That Matter: Ray & Rhonda's Long-Term Journey With HD Chorea 10:34 Hear From a Doctor: Diagnosing TD 03:19 Improvement Over Time: An Update on Charlene 2+ Years Later 08:44 Hear From a Doctor: Treating TD 08:53 Hear From a Doctor: What to Expect With a TD Treatment 08:58 Hear from a Person Living with TD: My TD Diagnosis Story 01:01 TV Commercial: As You Go With AUSTEDO® (deutetrabenazine) tablets 02:07 The Impact of TD: Charlene and Squirt 09:22 Rebecca's Story: My Truth About TD 02:46 Important Safety Information for healthcare providers 07:54 Hear From a Doctor: The Impact of TD 09:16 Hear from a Person Living with TD: The Impact of TD 05:03 Approved Uses and Important Safety Information for Patients 03:42 My Truth About Huntington's Disease (HD) Chorea: Patient Insight Similar videos 07:24 Deciphering the Diagnostic Landscape: Tardive Dyskinesia (TD) and Drug-Induced Parkinsonism (DIP) 08:16 Unraveling the Neurobiology of Tardive Dyskinesia (TD) and Drug-Induced Parkinsonism (DIP) 45:00 Tardive Dyskinesia Across the Complexity Spectrum 08:34 Differentiating tardive dyskinesia (TD) from acute extrapyramidal symptoms with Laxman Bahroo, DO 06:29 Expert-Driven Psychiatry Case: Tardive Dyskinesia, 2: Diagnosing Movement Disorders 10:15 Demystifying EPS & DIMD: Differential Diagnosis of TD 30:07 Tardive Syndrome (TS) Drug induced movement disorders 1:14:06 A New Era in the Diagnosis and Treatment of Tardive Dyskinesia 07:11 Demystifying EPS & DIMD: Operating Mechanisms of TD & DIP 31:37 Tardive Dyskinesia: Achieving and Maintaining Improved Quality of Life 11:30 Drugs and MPTP-induced Parkinsonism 1:00:41 Tardive Dyskinesia Across the Complexity Spectrum: Quality of Life Improvement to Novel Treatments 48:37 "It's a movement! Update on the Management of Tardive Dyskinesia", Mark LaBossire, PharmD, BCPP 42:31 TD360: Achieving and Maintaining Improved Quality of Life in Patients With Tardive Dyskinesia 55:35 Tardive Dyskinesia: Strategies for Patient Follow-Up and Long-Term VMAT2 Inhibitor Treatment 1:08:02 Tardive Dyskinesia: Symposium on Maintaining Improved Quality of LIfe 1:07:09 drug induced movement disorder More results